Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients.

The overview of the current covariates for pharmacokinetic variability of mTOR inhibitors has been provided on the level of absorption, distribution and elimination, and consequences of these relationships for dosing optimization has been summarized.